172 related articles for article (PubMed ID: 29966975)
1. HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc.
Qu H; Liu H; Jin Y; Cui Z; Han G
Biomed Pharmacother; 2018 Oct; 106():309-315. PubMed ID: 29966975
[TBL] [Abstract][Full Text] [Related]
2. R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc.
Lin TP; Li J; Li Q; Li X; Liu C; Zeng N; Huang JM; Chu GC; Lin CH; Zhau HE; Chung LWK; Wu BJ; Shih JC
Mol Cancer Res; 2018 Dec; 16(12):1940-1951. PubMed ID: 30042175
[TBL] [Abstract][Full Text] [Related]
3. Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
Bonazzoli E; Bellone S; Zammataro L; Gnutti B; Guglielmi A; Pelligra S; Nagarkatti N; Manara P; Tymon-Rosario J; Zeybek B; Altwerger G; Menderes G; Han C; Ratner E; Silasi DA; Huang GS; Andikyan V; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2020 Sep; 158(3):769-775. PubMed ID: 32600791
[TBL] [Abstract][Full Text] [Related]
4. The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression.
Yuan Y; Wang LH; Zhao XX; Wang J; Zhang MS; Ma QH; Wei S; Yan ZX; Cheng Y; Chen XQ; Zou HB; Ge J; Wang Y; Zhang X; Cui YH; Luo T; Bian XW
Cancer Commun (Lond); 2022 Sep; 42(9):868-886. PubMed ID: 35848447
[TBL] [Abstract][Full Text] [Related]
5. SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway.
Quan Y; Wang N; Chen Q; Xu J; Cheng W; Di M; Xia W; Gao WQ
Oncotarget; 2015 Sep; 6(28):26494-507. PubMed ID: 26317998
[TBL] [Abstract][Full Text] [Related]
6. Tumour suppressive function of HUWE1 in thyroid cancer.
Ma W; Zhao P; Zang L; Zhang K; Liao H; Hu Z
J Biosci; 2016 Sep; 41(3):395-405. PubMed ID: 27581931
[TBL] [Abstract][Full Text] [Related]
7. A novel SNP in HUWE1 promoter confers increased risk of NOA by affecting the RA/RARα pathway in Chinese individuals.
Shan X; Zhang X; Huang G; Lv J; Ye Z; Jiang C; Jiang X; Cheng J; Lin H; Jiang H; Yue H; Wang Z; Xu W
Andrology; 2024 Feb; 12(2):338-348. PubMed ID: 37290064
[TBL] [Abstract][Full Text] [Related]
8. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
9. The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma.
Crawford LJ; Campbell DC; Morgan JJ; Lawson MA; Down JM; Chauhan D; McAvera RM; Morris TC; Hamilton C; Krishnan A; Rajalingam K; Chantry AD; Irvine AE
Oncogene; 2020 Jul; 39(27):5001-5014. PubMed ID: 32523091
[TBL] [Abstract][Full Text] [Related]
10. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.
Fan L; Peng G; Sahgal N; Fazli L; Gleave M; Zhang Y; Hussain A; Qi J
Oncogene; 2016 May; 35(19):2441-52. PubMed ID: 26279298
[TBL] [Abstract][Full Text] [Related]
11. Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models.
Kunz V; Bommert KS; Kruk J; Schwinning D; Chatterjee M; Stühmer T; Bargou R; Bommert K
Sci Rep; 2020 Oct; 10(1):18419. PubMed ID: 33116152
[TBL] [Abstract][Full Text] [Related]
12. The MULE/HUWE1 E3 ubiquitin ligase is a tumor suppressor.
Cancer Discov; 2013 Jul; 3(7):OF32. PubMed ID: 23847377
[TBL] [Abstract][Full Text] [Related]
13. TRIM37 promotes the aggressiveness of ovarian cancer cells and increases c-Myc expression by binding to HUWE1.
Li D; Zhang Z
Arch Biochem Biophys; 2022 Oct; 728():109372. PubMed ID: 35921902
[TBL] [Abstract][Full Text] [Related]
14. ATG101 Degradation by HUWE1-Mediated Ubiquitination Impairs Autophagy and Reduces Survival in Cancer Cells.
Lee J; Kim J; Shin J; Kang Y; Choi J; Cheong H
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502089
[TBL] [Abstract][Full Text] [Related]
15. The E3 ligase HUWE1 mediates TGFBR2 ubiquitination and promotes gastric cancer cell proliferation, migration, and invasion.
He Y; Zhou J; Wan Q
Invest New Drugs; 2021 Jun; 39(3):713-723. PubMed ID: 33405091
[TBL] [Abstract][Full Text] [Related]
16. The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain.
Zhao X; D' Arca D; Lim WK; Brahmachary M; Carro MS; Ludwig T; Cardo CC; Guillemot F; Aldape K; Califano A; Iavarone A; Lasorella A
Dev Cell; 2009 Aug; 17(2):210-21. PubMed ID: 19686682
[TBL] [Abstract][Full Text] [Related]
17. Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.
Inoue S; Hao Z; Elia AJ; Cescon D; Zhou L; Silvester J; Snow B; Harris IS; Sasaki M; Li WY; Itsumi M; Yamamoto K; Ueda T; Dominguez-Brauer C; Gorrini C; Chio II; Haight J; You-Ten A; McCracken S; Wakeham A; Ghazarian D; Penn LJ; Melino G; Mak TW
Genes Dev; 2013 May; 27(10):1101-14. PubMed ID: 23699408
[TBL] [Abstract][Full Text] [Related]
18. Significantly altered expression of miR-511-3p and its target AKT3 has negative prognostic value in human prostate cancer.
Zhang F; Wu Z
Biochimie; 2017 Sep; 140():66-72. PubMed ID: 28624527
[TBL] [Abstract][Full Text] [Related]
19. The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein.
Zhao X; Heng JI; Guardavaccaro D; Jiang R; Pagano M; Guillemot F; Iavarone A; Lasorella A
Nat Cell Biol; 2008 Jun; 10(6):643-53. PubMed ID: 18488021
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-384 is lowly expressed in human prostate cancer cells and has anti-tumor functions by acting on HOXB7.
Hong Z; Fu W; Wang Q; Zeng Y; Qi L
Biomed Pharmacother; 2019 Jun; 114():108822. PubMed ID: 30951946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
